Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 12 Breast Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 5 Prostatic Neoplasms 4 Solid Tumor 3 Neoplasm Metastasis 3 Melanoma 3 Recurrence 2 Pancreatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Gastrointestinal Stromal Tumors 2 Colonic Neoplasms 2 Choledocholithiasis 2 Carcinoma 2 Advanced Solid Tumor 2 cMET-dysregulated Advanced Solid Tumors 1 Terminal Cancer 1 Synovitis, Pigmented Villonodular 1 Stomach Neoplasms 1 Solid Tumours 1 Solid Tumour 1 Solid Tumors 1 Skin Neoplasms 1 Respiratory Aspiration 1 Respiration Disorders 1 Rectal Neoplasms 1 Rare Diseases 1 Prostate Cancer Patients 1

Interventions

Bupivacaine 18 Ropivacaine 10 Saline Solution 9 Dexmedetomidine 9 Sodium Chloride 5 Pregabalin 5 Morphine 5 Ketamine 5 Lidocaine 4 Dexamethasone 4 Control Groups 4 Analgesia, Patient-Controlled 4 Tea 3 Gabapentin 3 Anesthetics, Local 3 Acetaminophen 3 Population Groups 2 Parapsychology 2 Magnesium Sulfate 2 Injections, Epidural 2 Fentanyl 2 Dental Occlusion 2 Anti-Inflammatory Agents, Non-Steroidal 2 Analgesics, Opioid 2 thiamine triphosphorate 1 ramosetron 1 parecoxib 1 gamma-Aminobutyric Acid 1 esmolol 1 Water 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pain, Postoperative × Midazolam × Clear all

NCT06315634 2024-03-18

Intrathecal Dexmedetomidine vs Midazolame

National Cancer Institute, Egypt

Phase 4 Completed

Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡